Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marchioro

Showing results (341-350 of 358) with videos related to

Pageof 36
Sort By:
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Einstein (Sao Paulo, Brazil)|October 25, 2023
Determining reference ranges for immunological cells of healthy indigenous individuals from a region in BrazilIsa Rita Brito de Morais, Dyjaene de Oliveira Barbosa, Gabriel Barroso de Almeida, et al.
Journal of Medicinal Chemistry|February 23, 2010
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitorsFabrizio Micheli, Paolo Cavanni, Roberto Arban, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Frontiers in Veterinary Science|March 5, 2021
Comparative Proteomic Analyses Between Biofilm-Forming and Non-biofilm-Forming Strains of <i>C</i>o<i>rynebacterium pseudotuberculosis</i> Isolated From GoatsMaria Conceição Aquino de Sá, Wanderson Marques da Silva, Carla Catarine Santos Rodrigues, et al.
International Journal of Molecular Sciences|April 30, 2021
Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2016
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional databaseRiccardo Schiavina, Lorenzo Bianchi, Marco Borghesi, et al.
Plos One|December 22, 2023
Seroprevalence Of SARS-COV-2 infection in asymptomatic indigenous from the largest Brazilian periurban areaLaís Albuquerque de Oliveira, Marcelo Dos Santos Barbosa, Alex José Leite Torres, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Einstein (Sao Paulo, Brazil)|October 25, 2023
Determining reference ranges for immunological cells of healthy indigenous individuals from a region in BrazilIsa Rita Brito de Morais, Dyjaene de Oliveira Barbosa, Gabriel Barroso de Almeida, et al.
Journal of Medicinal Chemistry|February 23, 2010
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitorsFabrizio Micheli, Paolo Cavanni, Roberto Arban, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Frontiers in Veterinary Science|March 5, 2021
Comparative Proteomic Analyses Between Biofilm-Forming and Non-biofilm-Forming Strains of <i>C</i>o<i>rynebacterium pseudotuberculosis</i> Isolated From GoatsMaria Conceição Aquino de Sá, Wanderson Marques da Silva, Carla Catarine Santos Rodrigues, et al.
International Journal of Molecular Sciences|April 30, 2021
Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2016
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional databaseRiccardo Schiavina, Lorenzo Bianchi, Marco Borghesi, et al.
Plos One|December 22, 2023
Seroprevalence Of SARS-COV-2 infection in asymptomatic indigenous from the largest Brazilian periurban areaLaís Albuquerque de Oliveira, Marcelo Dos Santos Barbosa, Alex José Leite Torres, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Pageof 36